Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324

Activation of microglial cells by β-amyloid protein and interferon-γ

Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314

Characterization of ameboid microglia isolated from developing mammalian brain

Giulian, D., & Baker, T. J. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02163.1986 · Cited by 1,300

STRUCTURES AND FUNCTIONS OF MULTILIGAND LIPOPROTEIN RECEPTORS: Macrophage Scavenger Receptors and LDL Receptor-Related Protein (LRP)

Krieger, M., & Krieger, J. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.63.1.601 · Cited by 1,169

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

Quinn, M. T., Parthasarathy, S., Fong, L. G., & Steinberg, D. I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2995 · Cited by 1,138

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806

Advanced Maillard reaction end products are associated with Alzheimer disease pathology.

Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 715

Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity

Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699

Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor

Fraser, I. P., Hughes, D. A., & Gordon, S. (1993) · Nature · doi:10.1038/364343a0 · Cited by 341

beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.

Jiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330

Amyloid beta peptide causes chronic glial cell activation and neuro‐degeneration after intravitreal injection

Walsh, D. T., Bresciani, L. G., Saunders, D., Manca, M. F., Jen, A., Gentleman, S., & Jen, L. S. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00666.x · Cited by 45

A fibril-specific, conformation-dependent antibody recognizes a subset of Aβ plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain

Sarsoza, F. M., Saing, T., Kayed, R., Dahlin, R., Dick, M. B., Broadwater-Hollifield, C., Mobley, S., Lott, I. T., Doran, E. W., Gillen, D. L., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0530-3 · Cited by 44

beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins.

Kunjathoor, V. V., Tseng, A. A., Medeiros, L. A., Khan, T., & Moore, K. J. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-23 · Cited by 44

Multiple Sclerosis and Central Nervous System Demyelination

Pouly, S., & Antel, J. P. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0321 · Cited by 44

Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease

Schröder, N., Schaffrath, A., Welter, J. A., Putzka, T., Griep, A., Ziegler, P., Brandt, E., Samer, S., Heneka, M. T., Kaddatz, H., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01816-2 · Cited by 43

Activated Scavenger Receptor A Promotes Glial Internalization of Aβ

Zhang, H., Su, Y., Zhou, W.-W., Wang, S.-W., Xu, P., Yu, X., & Liu, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094197 · Cited by 43

Inositol-trisphosphate-dependent intercellular calcium signaling in and between astrocytes and endothelial cells

Leybaert, L., Paemeleire, K., Strahonja, A., & Sanderson, M. J. (1998) · Glia · doi:10.1002/(sici)1098-1136(199812)24:4 · Cited by 144

Glial reactions and the clearance of amyloid β protein in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type

Maat–Schieman, M. L. C., Yamaguchi, H., Hegeman-Kleinn, I. M., Welling‐Graafland, C., Natté, R., Roos, R. A. C., & van Duinen, S. G. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0824-4 · Cited by 45

Amyloid-β precursor protein mediates neuronal toxicity of amyloid β through Go protein activation

Vigo, F. S., Kedikian, G., Heredia, L., Heredia, F., Añel, A. D., Rosa, A. L., & Lorenzo, A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.017 · Cited by 42

Palmitoylation and processing of the lipopeptide surfactant protein C

ten Brinke, A., GOLDE, L. M. G. V., & Batenburg, J. J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00248-2 · Cited by 41

Modulation of Microglial Innate Immunity in Alzheimers Disease by Activation of Peroxisome Proliferator-activated Receptor Gamma

Shie, F., Nivison, M. P., Hsu, P.-C., & Montine, T. J. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787458399 · Cited by 41

SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus

Saleshando, G., & O'Connor, J. J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01210-6 · Cited by 41

Invited Review – Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials

Boche, D., & Nicoll, J. A. R. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12642 · Cited by 41

Microglia kill amyloid-β1-42 damaged neurons by a CD14-dependent process

Bate, C., Veerhuis, R., Eikelenboom, P., & Williams, A. (2004) · Neuroreport · doi:10.1097/01.wnr.0000132203.76836.16 · Cited by 40

Pre-aggregated Aβ25–35 alters arginine metabolism in the rat hippocampus and prefrontal cortex

Liu, P., Yu, J. H., Collie, N. D., Campbell, S. A., & Zhang, H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.054 · Cited by 40

Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex

Leung, E., Guo, L., Bu, J., Maloof, M. E., Khoury, J. B. E., & Geula, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.025 · Cited by 40

Imaging β-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerization

Shoghi, K. I., Barrio, J. R., Kepe, V., Wu, H.-M., Small, G. W., Phelps, M. E., & Huang, S. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.02.003 · Cited by 40

Involvement of Wiskott-Aldrich Syndrome Protein Family Verprolin-Homologous Protein (WAVE) and Rac1 in the Phagocytosis of Amyloid-β(1 – 42) in Rat Microglia

Kitamura, Y., Shibagaki, K., Takata, K., Tsuchiya, D., Taniguchi, T., Gebicke-Haerter, P. J., Miki, H., Takenawa, T., & Shimohama, S. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.92.115 · Cited by 39

The immune modulator FTY720 targets sphingosine–kinase‐dependent migration of human monocytes in response to amyloid beta‐protein and its precursor

Kaneider, N. C., Lindner, J., Feistritzer, C., Sturn, D. H., Mosheimer, B. A., Djanani, A. M., & Wiedermann, C. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1050fje · Cited by 39

Rhinacanthin C Alleviates Amyloid‐β Fibrils’ Toxicity on Neurons and Attenuates Neuroinflammation Triggered by LPS, Amyloid‐β, and Interferon‐γ in Glial Cells

Chuang, K., Li, M., Lin, N., Chang, C.-H., Lu, I.-H., Pan, I.-H., Takahashi, T., Perng, M., & Wen, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5414297 · Cited by 40

More Than Just a Removal Service: Scavenger Receptors in Leukocyte Trafficking

Patten, D. A., & Shetty, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02904 · Cited by 41

Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer’s Disease Brains

Soto-Rojas, L. O., Campa-Córdoba, B. B., Harrington, C. R., Salas‐Casas, A., Hernándes‐Alejandro, M., Villanueva‐Fierro, I., Bravo-Muñoz, M., Garcés‐Ramírez, L., de la Cruz‐López, F., Ontiveros‐Torres, M. Á., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073654 · Cited by 41

Menopausal transition: A possible risk factor for brain pathologic events

Bonomo, S., Rigamonti, A. E., Giunta, M., Galimberti, D., Guaita, A., Gagliano, M. G., Müller, E. E., & Cella, S. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.017 · Cited by 39

Cellular Cofactors for Amyloid β-Peptide-Induced Cell Stress

Yan, S. D., Roher, A. E., Schmidt, A. M., & Stern, D. M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65452-1 · Cited by 40

Class A Scavenger Receptor-mediated Macrophage Adhesion Requires Coupling of Calcium-independent Phospholipase A2 and 12/15-Lipoxygenase to Rac and Cdc42 Activation

Nikolic, D. M., Gong, M. C., TURK, J. W., & Post, S. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704133200 · Cited by 39

Microglia in Alzheimer's Disease and Transgenic Models

Dickson, D. W. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65416-8 · Cited by 40

Factors influencing the processing and function of the amyloid β precursor protein—a potential therapeutic target in Alzheimer's disease?

Coughlan, C. M. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00036-x · Cited by 39

Inhibiting mtDNA‐STING‐NLRP3 / IL ‐1β axis‐mediated neutrophil infiltration protects neurons in Alzheimer's disease

Xia, X., He, X., Zhao, T., Yang, J., Bi, Z., Fu, Q., Liu, J., Ao, D., Wei, Y., & Wei, X. (2023) · Cell Proliferation · doi:10.1111/cpr.13529 · Cited by 38

Class A scavenger receptor-mediated cell adhesion requires the sequential activation of Lyn and PI3-kinase

Nikolic, D. M., Cholewa, J., Gass, C., Gong, M. C., & Post, S. R. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00401.2006 · Cited by 38

Inflammation as a Possible Link Between Dyslipidemia and Alzheimer’s Disease

Oliveira, B. C. D. L., Bellozi, P. M. Q., Reis, H. J., & de Oliveira, A. C. P. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.012 · Cited by 39

A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis

Xue, D., Zhao, M., Wang, Y., Wang, L., Yang, Y., Wang, S., Zhang, R., Zhao, Y., & Liu, R. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.013 · Cited by 39

Chronic Amyloid β Oligomer Infusion Evokes Sustained Inflammation and Microglial Changes in the Rat Hippocampus via NLRP3

Fekete, C., Vastagh, C., Dénes, Á., Hrabovszky, E., Nyíri, G., Kalló, I., Liposits, Z., & Sárvári, M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.046 · Cited by 39

Molecular Pathology of Alzheimer’s Disease and Related Disorders

Ginsberg, S. D., Schmidt, M. L., Crino, P. B., Eberwine, J. H., Lee, V. M. ‐., & Trojanowski, J. Q. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_17 · Cited by 38

The collagenous domain of class A scavenger receptors is involved in macrophage adhesion to collagens

Gowen, B. B., Borg, T. K., Ghaffar, A., & Mayer, E. P. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.575 · Cited by 38

Regression stage senile plaques in the natural course of Alzheimer’s disease

Oide, T., Kinoshita, T., & Arima, K. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00767.x · Cited by 39

Peli1 impairs microglial Aβ phagocytosis through promoting C/EBPβ degradation

Xu, J., Yu, T., Pietronigro, E. C., Yuan, J., Arioli, J., Pei, Y., Luo, X., Ye, J., Constantin, G., Mao, C., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000837 · Cited by 37

Amyloid β peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology

Kar, S., & Quirion, R. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45018-8 · Cited by 37

Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model

Wang, Q., Xu, Y., Chen, J., Qin, Y., Liu, M., Liu, Y., Xie, M.-J., Yu, Z., Zhu, Z., & Wang, W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.011 · Cited by 39

Redox imbalance and immune functions: opposite effects of oxidized low‐density lipoproteins and N‐acetylcysteine

Viora, M., Quaranta, M. G., Straface, E., Varı́, R., Masella, R., & Malorni, W. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01334.x · Cited by 37

Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology

Gebril, H. M., Aryasomayajula, A., de Lima, M. R. N., Uhrich, K. E., & Moghe, P. V. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-023-00393-7 · Cited by 37

Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer’s disease

Manral, A., Saini, V., Meena, P., & Tiwari, M. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.08.024 · Cited by 36

Microglia Do Not Take Up Soluble Amyloid-beta Peptides, But Partially Degrade Them by Secreting Insulin-degrading Enzyme

Fu, H., Liu, B., Li, L., & Lemere, C. A. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.07.020 · Cited by 36

Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation

Streit, W. J., Rotter, J., Winter, K., Müller, W. C., Khoshbouei, H., & Bechmann, I. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215334 · Cited by 37

Amyloid β neurotoxicity in the cholinergic but not in the serotonergic phenotype of RN46A cells

Olesen, O. F., Dagø, L., & Mikkelsen, J. D. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00096-5 · Cited by 36

Aging and the neurovascular unit

del Zoppo, G. J. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06686.x · Cited by 35

Expression Pattern of Scavenger Receptors and Amyloid-β Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer’s Disease

Eugenín, J. L., Vecchiola, A., Murgas, P., Arroyo, P., Cornejo, F., & Rommy von Bernhardi, M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160083 · Cited by 35

Review of Amyotrophic Lateral Sclerosis, Parkinson’s and Alzheimer’s diseases helps further define pathology of the novel paradigm for Alzheimer’s with heavy metals as primary disease cause

Cavaleri, F. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.10.009 · Cited by 36

Alzheimer's disease: An inflammatory disease?

Fassbender, K. C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00147-0 · Cited by 35

The secretases of Alzheimer's disease

Wolfe, M. S. (2003) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(03)54011-x · Cited by 35

The lysine cluster in the collagen‐like domain of the scavenger receptor provides for its ligand binding and ligand specificity

Yamamoto, K., Nishimura, N., Doi, T., IMANISHI, T., Kodama, T., Suzuki, K. T., & Tanaka, T. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01006-5 · Cited by 35

The adhesion and migration of microglia to β-amyloid (Aβ) is decreased with aging and inhibited by Nogo/NgR pathway

Fang, Y., Wang, J., Yao, L., Li, C., Wang, J., Liu, Y., Tao, X., Sun, H., & Liao, H. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1250-1 · Cited by 35

CD36 Participates in PrP106–126-Induced Activation of Microglia

Kouadir, M., Yang, L., Tan, R., Shi, F., Lu, Y., Zhang, S., Yin, X., Zhou, X., & Zhao, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030756 · Cited by 34

Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives

Bhole, R. P., Chikhale, R. V., & Rathi, K. M. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.11.003 · Cited by 34

Mechanism of amyloid peptide induced CCR5 expression in monocytes and its inhibition by siRNA for Egr-1

Giri, R. K., Rajagopal, V., Shahi, S., Zloković, B. V., & Kalra, V. K. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00461.2004 · Cited by 34

Can Blood–Brain Barrier Play a Role in the Development of Cerebral Amyloidosis and Alzheimer's Disease Pathology

Zloković, B. V. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0134 · Cited by 36

Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer’s disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction

Yang, W., Xu, Q., Yuan, Q., Xian, Y., & Lin, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109504 · Cited by 33

Oligonucleotide aggregates bind to the macrophage scavenger receptor

Suzuki, K. T., Doi, T., Imanishi, T., Kodama, T., & Tanaka, T. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00233.x · Cited by 33

Proteomic identification of a novel protein regulated in CA1 and CA3 hippocampal regions during intermittent hypoxia

Klein, J. B., Gozal, D., Pierce, W. M. J., Thongboonkerd, V., Scherzer, J. A., Sachleben, L. R., Guo, S., Cai, J., & Gozal, E. (2003) · Respiratory Physiology & Neurobiology · doi:10.1016/s1569-9048(03)00074-0 · Cited by 33

Amyloid β Protein (25‐35) Phosphorylates MARCKS Through Tyrosine Kinase‐Activated Protein Kinase C Signaling Pathway in Microglia

Nakai, M., Hojo, K., Yagi, K., Saito, N., Taniguchi, T., Terashima, A., Kawamata, T., Hashimoto, T., Maeda, K., Gschwendt, M., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721179.x · Cited by 33

Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1‐associated dementia

Smits, Boven, Pereira, Verhoef, & Nottet (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00661.x · Cited by 33

Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies

Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 33

Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β1–40 Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems

Martins, W. C., dos Santos, V. V., dos Santos, A. A., Vandresen-Filho, S., Dal-Cim, T. A., de Oliveira, K. A., Nedel, C. B., Farina, M., Prediger, R. D., Viola, G. G., et al. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9527-y · Cited by 31

What Can Rodent Models Tell Us About Cognitive Decline in Alzheimer's Disease?

Davis, S., & Laroche, S. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:3:249 · Cited by 32

Glimepiride reduces CD14 expression and cytokine secretion from macrophages

Ingham, V. A., Williams, A., & Bate, C. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-115 · Cited by 31

Monocytes Reprogrammed by 4-PBA Potently Contribute to the Resolution of Inflammation and Atherosclerosis

Geng, S., Lu, R., Zhang, Y., Wu, Y., Xie, L., Caldwell, B. A., Pradhan, K., Yi, Z., Hou, J., Xu, F., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.325023 · Cited by 30

Neuroprotective Effect of Phthalide Derivative CD21 against Ischemic Brain Injury:Involvement of MSR1 Mediated DAMP peroxiredoxin1 Clearance and TLR4 Signaling Inhibition

Zou, X., Yang, X., Gan, Y.-M., Liu, D., Chen, C., Duan, W., & Du, J. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09911-0 · Cited by 30

Identification of synaptic plasma membrane proteins co‐precipitated with fibrillar β‐amyloid peptide

Verdier, Y., Huszár, E., Penke, B., Penke, Z., Woffendin, G., Ščigelová, M., Fülöp, L., Szűcs, M., Medzihradszky, K. F., & Janáky, T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03158.x · Cited by 30

Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid β (Aβ1-40) administration in mice

Souza, A. C. G., Gonçalves, C. L., de Souza, V., Hartwig, J. M., Farina, M., & Prediger, R. D. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.06.032 · Cited by 29

Correlated Inflammatory Responses and Neurodegeneration in Peptide-Injected Animal Models of Alzheimer’s Disease

McLarnon, J. G. (2014) · BioMed Research International · doi:10.1155/2014/923670 · Cited by 30

Oxidized High-Density Lipoprotein Induces Neuron Death

Keller, J. N., Hanni, K. B., & Kindy, M. S. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7276 · Cited by 30

A non-invasive method for measuring preimplantation embryo physiology

Trimarchi, J. R., Liu, L., Porterfield, D. M., Smith, P. J., & Keefe, D. L. (2000) · Zygote · doi:10.1017/s0967199400000782 · Cited by 29

Cajal's Contributions to the Study of Alzheimer's Disease

García‐Marín, V., García-López, P., & Freire, M. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12206 · Cited by 29

Suppression of Aβ-induced monocyte neurotoxicity by antiinflammatory compounds

Dzenko, K. A., Weltzien, R. B., & Pachter, J. S. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00128-8 · Cited by 29

The Role of the Amyloid Protein Precursor (APP) in Alzheimer's Disease: Does the Normal Function of APP Explain the Topography of Neurodegeneration?

Small, D. H. (1998) · Neurochemical Research · doi:10.1023/a:1022471729291 · Cited by 30

The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer’s Disease

Gao, P.-R., Ye, L., Cheng, H.-R., & Li, H. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00926-y · Cited by 34

Genetics of Alzheimer’s disease

König, T., & Stögmann, E. (2021) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-021-00819-9 · Cited by 31

Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis

Calafatti, M., Cocozza, G., Limatola, C., & Garofalo, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223096 · Cited by 29

Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?

Rommy von Bernhardi, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1248 · Cited by 28

Endomorphin‐2, an endogenous tetrapeptide, protects against Aβ1‐42 in vitro and in vivo

Szegedi, V., Juhász, G., Rozsa, É., Juhász-Vedres, G., Datki, Z., Fülöp, L., Bozsó, Z., Lakatos, A., Laczkó, I., Farkas, T., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4891fje · Cited by 30

CCAAT-enhancer binding proteinα is expressed in activated microglial cells after brain injury

Walton, M., Saura, J., Young, D., MacGibbon, G., Hansen, W., Lawlor, P., Sirimanne, E., Gluckman, P., & Dragunow, M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00169-7 · Cited by 28

Amyloid‐β peptides induce cell proliferation and macrophage colony‐stimulating factor expression via the PI3‐kinase/Akt pathway in cultured Ra2 microglial cells

Ito, S., Sawada, M., Haneda, M., Fujii, S., Oh‐hashi, K., Kiuchi, K., Takahashi, M., & Isobe, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.048 · Cited by 28

Bridging the Gap between Alzheimer’s Disease and Alzheimer’s-like Diseases in Animals

Gołaszewska, A., Bik, W., Motyl, T., & Orzechowski, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071664 · Cited by 31

The age-related microglial transformation in Alzheimer's disease pathogenesis

Yuan, C., Aierken, A., Xie, Z., Li, N., Zhao, J., & Qing, H. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.024 · Cited by 27

Involvement of small GTPase RhoA in the regulation of superoxide production in BV2 cells in response to fibrillar Aβ peptides

Moon, M.-Y., Kim, H.-J., Li, Y., Kim, J.-G., Jeon, Y.-J., Won, H.-Y., Kim, J.-S., Kwon, H.-Y., Choi, I.-G., Ro, E., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.023 · Cited by 27

Some aspects of astroglial functions and aluminum implications for neurodegeneration

Aremu, D. A., & Meshitsuka, S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.02.001 · Cited by 27

Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity

Bennett, N. K., Chmielowski, R., Abdelhamid, D. S., Faig, J. J., Francis, N. L., Baum, J., Pang, Z. P., Uhrich, K. E., & Moghe, P. V. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.001 · Cited by 27

The role of CD36 in peripheral nerve remyelination after crush injury

Eto, M., Yoshikawa, H., Fujimura, H., Naba, I., Sumi‐Akamaru, H., TAKAYASU, S., Itabe, H., & Sakoda, S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02711.x · Cited by 27

Microglia in Alzheimer’s Disease

Süß, P., & Schlachetzki, J. C. M. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200212155234 · Cited by 26

A Review of the Application of Hyperbaric Oxygen Therapy in Alzheimer’s Disease

Somaa, F. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210157 · Cited by 26

Structural and mechanistic commonalities of amyloid-β and the prion protein

Dias, B. D. C., Jovanovic, K., Gonsalves, D., & Weiss, S. F. T. (2011) · Prion · doi:10.4161/pri.5.3.17025 · Cited by 28

Pathogenic role of mitochondrial amyloid-β peptide

Chen, J. X., & Yan, S. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1517 · Cited by 26

Microglial responses to amyloid β peptide opsonization and indomethacin treatment

Strohmeyer, R., Kovelowski, C. J., Mastroeni, D., Leonard, B. W., Grover, A., & Rogers, J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-18 · Cited by 26

Oxidative stress impairs endocytosis of the scavenger receptor class A

Aguilar-Gaytán, R., & Mas‐Oliva, J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00796-4 · Cited by 27

A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes

Heininger, K. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199912)14:8 · Cited by 27

GRK5 deficiency exaggerates inflammatory changes in TgAPPsw mice

Li, L., Liu, J., & Suo, W. Z. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-24 · Cited by 26

Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia

Miwa, T., Furukawa, S., Nakajima, K., Furukawa, Y., & Kohsaka, S. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971215)50:6 · Cited by 181

Synthesis and stabilization of amino and carboxy terminal constrained collagenous peptides

Tanaka, Y., Suzuki, K. T., & Tanaka, T. (1998) · Journal of Peptide Research · doi:10.1111/j.1399-3011.1998.tb00639.x · Cited by 26

Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis

Su, Y., Li, H., Zhang, W., Tao, S., Wang, Q., Zhang, X., Zhou, M., Huang, X., Wang, C., Tang, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60746-w · Cited by 28

Role of Scavenger Receptors in Glia-Mediated Neuroinflammatory Response Associated with Alzheimer’s Disease

Cornejo, F., & Rommy von Bernhardi, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/895651 · Cited by 25

Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer’s disease

Wang, Z., & Weaver, D. F. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109070 · Cited by 26

Microglia, Scavenger Receptors, and the Pathogenesis of Alzheimer’s Disease

Khoury, J. B. E., Hickman, S., Thomas, C. A., Loike, J. D., & Silverstein, S. C. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00036-0 · Cited by 159

CD36, a Class B Scavenger Receptor, Is Expressed on Microglia in Alzheimer's Disease Brains and Can Mediate Production of Reactive Oxygen Species in Response to β-Amyloid Fibrils

Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., & El Khoury, J. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64354-4 · Cited by 398

Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar β-amyloid

Husemann, J., Loike, J. D., Kodama, T., & Silverstein, S. C. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00239-9 · Cited by 122

Expression of Scavenger Receptors in Glial Cells

Alarcón, R., Fuenzalida, C., Santibáñez, M., & Rommy von Bernhardi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414686200 · Cited by 159

A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation

Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., & Landreth, G. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02665.2003 · Cited by 501